Morphological study of remineralization of the eroded enamel lesions by tyrosine-rich amelogenin peptide.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 04 02 2024
accepted: 20 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Tyrosine-rich amelogenin peptide (TRAP) is the main amelogenin digestion product in the developmental enamel matrix. It has been shown to promote remineralization of demineralized enamel in our previous study. However, direct evidence of the effect of TRAP on the morphology and nanostructure of crystal growth on an enamel surface has not been reported. This study aimed to examine the effect of TRAP on the morphology of calcium phosphate crystals grown on early enamel erosion using a pH-cycling model. Eroded lesions were produced in human premolars by 30-second immersion in 37% phosphoric acid. Forty-five samples of eroded human premolar enamel blocks were selected and randomly divided into 3 groups: deionized water (DDW, negative control); 100 µg/mL TRAP, and 2 ppm sodium fluoride (NaF, positive control group). For 14 days, the specimens were exposed to a pH-cycling model. Using scanning electron microscopy (SEM) and atomic force microscopy (AFM) methods, the surface morphology, calcium-phosphorus ratio, and enamel surface roughness were examined. X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR) were used to assess crystal characteristics. After pH-cycling, compared to the two control groups, the surface of the eroded enamel of the peptide TRAP group shows a large number of new, densely arranged rod-like crystals, parallel to each other, regularly arranged, forming an ordered structure, with crystal morphology similar to that of natural enamel. The crystals are mostly hydroxyapatite (HA). This study demonstrates that the peptide TRAP modulates the formation of hydroxyapatite in eroded enamel and that the newly formed crystals resemble natural enamel crystals and promote the remineralization of enamel, providing a promising biomaterial for remineralization treatment of enamel lesions.

Sections du résumé

BACKGROUND BACKGROUND
Tyrosine-rich amelogenin peptide (TRAP) is the main amelogenin digestion product in the developmental enamel matrix. It has been shown to promote remineralization of demineralized enamel in our previous study. However, direct evidence of the effect of TRAP on the morphology and nanostructure of crystal growth on an enamel surface has not been reported. This study aimed to examine the effect of TRAP on the morphology of calcium phosphate crystals grown on early enamel erosion using a pH-cycling model.
METHODS METHODS
Eroded lesions were produced in human premolars by 30-second immersion in 37% phosphoric acid. Forty-five samples of eroded human premolar enamel blocks were selected and randomly divided into 3 groups: deionized water (DDW, negative control); 100 µg/mL TRAP, and 2 ppm sodium fluoride (NaF, positive control group). For 14 days, the specimens were exposed to a pH-cycling model. Using scanning electron microscopy (SEM) and atomic force microscopy (AFM) methods, the surface morphology, calcium-phosphorus ratio, and enamel surface roughness were examined. X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FT-IR) were used to assess crystal characteristics.
RESULTS RESULTS
After pH-cycling, compared to the two control groups, the surface of the eroded enamel of the peptide TRAP group shows a large number of new, densely arranged rod-like crystals, parallel to each other, regularly arranged, forming an ordered structure, with crystal morphology similar to that of natural enamel. The crystals are mostly hydroxyapatite (HA).
CONCLUSION CONCLUSIONS
This study demonstrates that the peptide TRAP modulates the formation of hydroxyapatite in eroded enamel and that the newly formed crystals resemble natural enamel crystals and promote the remineralization of enamel, providing a promising biomaterial for remineralization treatment of enamel lesions.

Identifiants

pubmed: 39252060
doi: 10.1186/s12903-024-04777-7
pii: 10.1186/s12903-024-04777-7
doi:

Substances chimiques

Amelogenin 0
Calcium Phosphates 0
calcium phosphate 97Z1WI3NDX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1054

Informations de copyright

© 2024. The Author(s).

Références

Dawes C. What is the critical pH and why does a tooth dissolve in acid? J Can Dent Assoc. 2003;69(11):722–4.
pubmed: 14653937
Lussi A, Jaggi T, Scharer S. The influence of different factors on in vitro enamel erosion. Caries Res. 1993;27(5):387–93.
doi: 10.1159/000261569 pubmed: 8242676
Huang Z, Newcomb CJ, Bringas P Jr., Stupp SI, Snead ML. Biological synthesis of tooth enamel instructed by an artificial matrix. Biomaterials. 2010;31(35):9202–11.
doi: 10.1016/j.biomaterials.2010.08.013 pubmed: 20869764 pmcid: 2956865
Dai LL, Mei ML, Chu CH, Lo ECM. Mechanisms of Bioactive Glass on Caries Management: a review. Mater (Basel) 2019, 12(24).
Cicciu M, Fiorillo L, Cervino G. Chitosan Use in Dentistry: a systematic review of recent clinical studies. Mar Drugs 2019, 17(7).
Iijima M, Tohda H, Suzuki H, Yanagisawa T, Moriwaki Y. Effects of F- on apatite-octacalcium phosphate intergrowth and crystal morphology in a model system of tooth enamel formation. Calcif Tissue Int. 1992;50(4):357–61.
doi: 10.1007/BF00301634 pubmed: 1571848
Philip N. State of the art Enamel Remineralization systems: the Next Frontier in Caries Management. Caries Res. 2019;53(3):284–95.
doi: 10.1159/000493031 pubmed: 30296788
Wang H, Xiao Z, Yang J, Lu D, Kishen A, Li Y, Chen Z, Que K, Zhang Q, Deng X, et al. Oriented and ordered biomimetic remineralization of the Surface of Demineralized Dental Enamel using HAP@ACP nanoparticles guided by Glycine. Sci Rep. 2017;7:40701.
doi: 10.1038/srep40701 pubmed: 28079165 pmcid: 5228061
Bartlett JD, Simmer JP. Proteinases in developing dental enamel. Crit Rev Oral Biol Med. 1999;10(4):425–41.
doi: 10.1177/10454411990100040101 pubmed: 10634581
Dissanayake SSM, Ekambaram M, Li KC, Harris PWR, Brimble MA. Identification of key functional motifs of native amelogenin protein for Dental Enamel Remineralisation. Molecules 2020, 25(18).
Paine ML, Snead ML. Protein interactions during assembly of the enamel organic extracellular matrix. J Bone Min Res. 1997;12(2):221–7.
doi: 10.1359/jbmr.1997.12.2.221
Chu J, Feng X, Guo H, Zhang T, Zhao H, Zhang Q. Remineralization efficacy of an amelogenin-based synthetic peptide on Carious Lesions. Front Physiol. 2018;9:842.
doi: 10.3389/fphys.2018.00842 pubmed: 30026702 pmcid: 6041723
Ravindranath RM, Tam WY, Nguyen P, Fincham AG. The enamel protein amelogenin binds to the N-acetyl-D-glucosamine-mimicking peptide motif of cytokeratins. J Biol Chem. 2000;275(50):39654–61.
doi: 10.1074/jbc.M006471200 pubmed: 10980199
Li Y, Li Y, Bai Q, Wen M, Ma D, Lin Y, Chu J. Recombinant amelogenin peptide TRAP promoting remineralization of early enamel caries: an in vitro study. Front Physiol. 2023;14:1076265.
doi: 10.3389/fphys.2023.1076265 pubmed: 36755789 pmcid: 9899998
Ding L, Han S, Wang K, Zheng S, Zheng W, Peng X, Niu Y, Li W, Zhang L. Remineralization of enamel caries by an amelogenin-derived peptide and fluoride in vitro. Regen Biomater. 2020;7(3):283–92.
doi: 10.1093/rb/rbaa003 pubmed: 32523730 pmcid: 7266664
White DJ. Reactivity of fluoride dentifrices with artificial caries. I. effects on early lesions: F uptake, surface hardening and remineralization. Caries Res. 1987;21(2):126–40.
doi: 10.1159/000261013 pubmed: 3469028
ten Cate JM, Duijsters PP. Influence of fluoride in solution on tooth demineralization. II. Microradiographic data. Caries Res. 1983;17(6):513–9.
doi: 10.1159/000260711 pubmed: 6580076
Mei ML, Nudelman F, Marzec B, Walker JM, Lo ECM, Walls AW, Chu CH. Formation of Fluorohydroxyapatite with Silver Diamine Fluoride. J Dent Res. 2017;96(10):1122–8.
doi: 10.1177/0022034517709738 pubmed: 28521107 pmcid: 5582683
Hicks MJ, Silverstone LM. Internal morphology of surface zones from acid-etched caries-like lesions: a scanning electron microscopic study. J Dent Res. 1985;64(11):1296–301.
doi: 10.1177/00220345850640110901 pubmed: 3912417
Kwak SY, Litman A, Margolis HC, Yamakoshi Y, Simmer JP. Biomimetic enamel regeneration mediated by Leucine-Rich Amelogenin Peptide. J Dent Res. 2017;96(5):524–30.
doi: 10.1177/0022034516688659 pubmed: 28113034 pmcid: 5453497
Dogan S, Fong H, Yucesoy DT, Cousin T, Gresswell C, Dag S, Huang G, Sarikaya M. Biomimetic tooth repair: amelogenin-derived peptide enables in Vitro Remineralization of Human Enamel. ACS Biomater Sci Eng. 2018;4(5):1788–96.
pubmed: 33445335
Moradian-Oldak J, Iijima M, Bouropoulos N, Wen HB. Assembly of amelogenin proteolytic products and control of octacalcium phosphate crystal morphology. Connect Tissue Res. 2003;44(Suppl 1):58–64.
doi: 10.1080/03008200390152106 pubmed: 12952175
Liu Y, Ding C, He L, Yang X, Gou Y, Xu X, Liu Y, Zhao C, Li J, Li J. Bioinspired heptapeptides as functionalized mineralization inducers with enhanced hydroxyapatite affinity. J Mater Chem B. 2018;6(13):1984–94.
doi: 10.1039/C7TB03067C pubmed: 32254364
Lippert F, Parker DM, Jandt KD. In vitro demineralization/remineralization cycles at human tooth enamel surfaces investigated by AFM and nanoindentation. J Colloid Interface Sci. 2004;280(2):442–8.
doi: 10.1016/j.jcis.2004.08.016 pubmed: 15533417
Paine ML, Snead ML. Tooth developmental biology: disruptions to enamel-matrix assembly and its impact on biomineralization. Orthod Craniofac Res. 2005;8(4):239–51.
doi: 10.1111/j.1601-6343.2005.00346.x pubmed: 16238604
Lench NJ, Winter GB. Characterisation of molecular defects in X-linked amelogenesis imperfecta (AIH1). Hum Mutat. 1995;5(3):251–9.
doi: 10.1002/humu.1380050310 pubmed: 7599636
Collier PM, Sauk JJ, Rosenbloom SJ, Yuan ZA, Gibson CW. An amelogenin gene defect associated with human X-linked amelogenesis imperfecta. Arch Oral Biol. 1997;42(3):235–42.
doi: 10.1016/S0003-9969(96)00099-4 pubmed: 9188994
Matsumoto T, Okazaki M, Inoue M, Sasaki J, Hamada Y, Takahashi J. Role of acidic amino acid for regulating hydroxyapatite crystal growth. Dent Mater J. 2006;25(2):360–4.
doi: 10.4012/dmj.25.360 pubmed: 16916241
Wiedemann-Bidlack FB, Kwak SY, Beniash E, Yamakoshi Y, Simmer JP, Margolis HC. Effects of phosphorylation on the self-assembly of native full-length porcine amelogenin and its regulation of calcium phosphate formation in vitro. J Struct Biol. 2011;173(2):250–60.
doi: 10.1016/j.jsb.2010.11.006 pubmed: 21074619
Le Norcy E, Kwak SY, Wiedemann-Bidlack FB, Beniash E, Yamakoshi Y, Simmer JP, Margolis HC. Leucine-rich amelogenin peptides regulate mineralization in vitro. J Dent Res. 2011;90(9):1091–7.
doi: 10.1177/0022034511411301 pubmed: 21653221 pmcid: 3169881
Fan Y, Sun Z, Moradian-Oldak J. Controlled remineralization of enamel in the presence of amelogenin and fluoride. Biomaterials. 2009;30(4):478–83.
doi: 10.1016/j.biomaterials.2008.10.019 pubmed: 18996587
Chen Y, Miao X. Thermal and chemical stability of fluorohydroxyapatite ceramics with different fluorine contents. Biomaterials. 2005;26(11):1205–10.
doi: 10.1016/j.biomaterials.2004.04.027 pubmed: 15475049

Auteurs

Mingzhu Wen (M)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Qinghua Bai (Q)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Yiwei Li (Y)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Yaru Li (Y)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Dandan Ma (D)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Jinpu Chu (J)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. cjp605@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH